Tumor necrosis factor-alpha and myocardial function in patients with myotonic dystrophy type 1

Journal of the Neurological Sciences

Volumn 201, Issue 1-2, 2002, Pages 59-64

  Mammarella, Antonio ^a   Ferroni, Patrizia ^a   Paradiso, Michele ^a   Martini, Francesca ^a   Paoletti, Vincenzo ^a   Morino, Stefania ^b   Antonini, Giovanni ^b   Gazzaniga, Pier Paolo ^a   Musca, Antonino ^a   Basili, Stefania ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cytokines; Diastolic function; Myotonic dystrophy type 1; QT dispersion; Tumor necrosis factor alpha; Ventricular late potentials

Indexed keywords

CYTOSINE; GUANINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; THYMINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLE; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; HEART AUTOMATICITY; HEART CONDUCTION; HEART FUNCTION; HEART MUSCLE FIBROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; AGED; ARRHYTHMIA; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; FIBROSIS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIUM; MYOTONIC DYSTROPHY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037106022     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00193-4     Document Type: Article

References (36)

1. Cardiac disease in myotonic dystrophy
2. New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1)
3. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member
4. An unstable triplet repeat in a gene related to myotonic muscular dystrophy
5. Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene
6. A 10-year study of mortality in a cohort of patients with myotonic dystrophy
7. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production: Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute cachexia
8. Haemostatic abnormalities, cardiac involvement, and serum tumor necrosis factor levels in X-linked dystrophic patients
9. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy
10. Diurnal rhythms of pro-inflammatory cytokines: Regulation by plasma cortisol and therapeutic implications
11. Abnormal cytokine and adrenocortical hormone regulation in myotonic dystrophy
12. Cytokines as emerging targets in the treatment of heart failure
13. Proinflammatory cytokines in heart disease
14. Echocardiographic evaluation of posterior left ventricular wall motion in muscular dystrophy
15. Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): A prospective study of 25 patients
16. Pathology of the cardiac conduction system in myotonic dystrophy
17. Cardiomyopathy in myotonic dystrophy: A light and electron microscopic study of the myocardium
18. Myotonia dystrophica with heart involvement: An electron microscopic study of skeletal, cardiac, and smooth muscle
19. Cardiac abnormalities in myotonic dystrophy: Electrophysiologic and histopathologic studies
20. Signal-averaged electrocardiography in myotonic dystrophy
21. Ventricular tachycardia and sudden death in myotonic dystrophy
22. Myocardial myotonia in myotonic muscular dystrophy
23. Doppler echocardiographic assessment of left ventricular diastolic function in myotonic distrophy
24. The natural history of cardiac involvement in myotonic dystrophy: An 8-year follow-up in 17 patients
25. QT dispersion
26. Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction
27. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography. A statement by a Task Force Committee between the European Society of Cardiology, the American Heart Association and the American College of Cardiology
28. Ventricular late potentials in myotonic dystrophy
29. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy
30. Dispersion of QT interval in premature ventricular beats as a marker of susceptibility to arrhythmic events
31. Increased platelet aggregation and release reaction in myotonic dystrophy
32. Platelet aggregation in myotonia
33. Myocardial extracellular matrix remodelling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy
34. Relation between late potentials on the body surface and directly recorded fragmented electrocardiograms in patients with ventricular tachycardia
35. Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?